Recruiting NCT06981624
Comparison of the Systematic Versus the Selective Use of Heparin for the Prevention of Radial Artery Occlusion
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: No heparin.
- Who it may be relevant to
- Registry conditions: Radial Artery Occlusion. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Canada
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Comparaison d'un Traitement systématique à l'héparine Versus sélectif Pour la prévention de l'Occlusion Radiale EASY-Héparine
Overview
Randomized study comparing the systematic use of heparin (standard of care) against an elective use of heparin to prevent radial artery occlusion after a percutaneous catheterization using a dual-artery compression system.
Interventions
- Other No heparin
Hemostasis achieved using a dual-artery compression device without administration of heparin after trans-radial diagnostic catheterization
Primary outcome measures
- Rates of patent hemostasis [Time frame: within 24 hours after diagnostic angiography]
- Time to hemostasis [Time frame: within 24 hours post-procedure]
- Nursing time involvement [Time frame: within 24 hours post-procedure]
- Evaluation of complications [Time frame: within 30 days of procedure]
Eligibility criteria
Inclusion criteria
- Any patient referred for a diagnostic transradial catheterism
Exclusion criteria
- Unable to understand study design or provide informed consent
- Unable to receive antiplatelet therapy with aspirina and/or clopidogrel-prasugrel and/or ticagrelor and intravenous anticoagulant derived from heparine or bivalirudine
- Local condition such as hematoma or pseudo-aneurims precluding radial or ulnar access.
- Presence of plethysmographic waveform with simultaneous radial and ulnar occlusive compression (due to colaterals or interouseous artery) precluding the evaluation of patent hemostasis.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Prevention
Study locations
Canada · 1 center
- IUCPQ — Québec
Identifiers
NCT: NCT06981624 · EASY-Heparin